Breast cancer advancements expected in 2018

December 29, 2017 06:13 AM

The opioid crisis and attempts to repeal Obamacare topped health news in 2017. So what can we expect in the new year?

Researchers are expecting advancements in more targeted treatments for breast cancer. These drugs attack specific pathways in cancer cells and are already on the market for ovarian cancer.

Advertisement – Content Continues Below

There is hope the FDA will approve them for use in breast cancer in 2018.


WNYT Staff

Copyright 2017 - WNYT-TV, LLC A Hubbard Broadcasting Company

Relay Media Amp
NXIVM leader facing new charges

Troy holds annual walk-a-mile

Four seriously injured in Rt. 146 crash

Man arrested for armed robbery

N. Korea, setting stage for talks, halts nuclear, ICBM tests